Piezocatalytic Sulfonation Enables Nongenetic Competition Therapy for Colorectal Cancer

Irreversible post-translational modifications provide a potential means to impose persistent changes in protein function, yet their controlled generation inside living cells remains challenging. Here, we develop an ultrasound-responsive potassium sodium niobate–gold (KNN@Au) piezoelectric nanoheterojunction functionalized with hyaluronic acid (KNN@Au-HA) to enable in situ terminal protein sulfonation. Under ultrasound excitation, the dynamic modulation of KNN polarization generates a piezo-potential that facilitates interfacial charge separation and electron transfer, promoting the single-electron reduction of O2 to •O2–. Meanwhile, Au–S coordination positions thiol substrates in close proximity to the catalytic surface, facilitating the subsequent multistep oxidation of cysteine thiols to the terminal −SO3H state. Using this platform, we identify ribosomal protein RPL32 as a functionally relevant sulfonation target and resolve sulfonation at Cys96 by mass spectrometry. This modification disrupts ribosomal proteostasis, induces NRF2 nuclear translocation and stress signaling, and converts colorectal cancer cells into a competitive “loser” state that undergoes neighbor-dependent apoptotic elimination. In HCT116 xenograft-bearing mice, ultrasound-activated KNN@Au-HA suppresses colorectal tumor growth; analysis of patient-derived single-cell transcriptomic data reveals RPL32 upregulation as a hallmark of the malignant “winner” state, establishing a functional match between this competition therapy and colorectal cancer. Together, these findings demonstrate that piezocatalytic protein modification can chemically reprogram cellular competitive fitness without genome editing, providing a proof of concept for nongenetic competition therapy against cancer.

Authors

Institutions

Publication Details

Journal
Journal of the American Chemical Society
Published
2026-11-19
DOI
https://doi.org/10.1021/jacs.6c20155
Primary Topic
Nanoplatforms for cancer theranostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Piezocatalytic Sulfonation Enables Nongenetic Competition Therapy for Colorectal Cancer

Jiyue Wu, Wenbo Bu, Chaochao Wang, 季敏标 Ji Minbiao et al.
Journal of the American Chemical Society
Nanoplatforms for cancer theranostics
article

Piezocatalytic Sulfonation Enables Nongenetic Competition Therapy for Colorectal Cancer

Jiyue Wu, Wenbo Bu, Chaochao Wang, 季敏标 Ji Minbiao, Yelin WU, Peiran Zhao, 王振华, Tianlei Ying, Jieyun Shi, Yun Meng, Yang Chen, Hao Chen, Jinghan Wang
article en

Abstract

Irreversible post-translational modifications provide a potential means to impose persistent changes in protein function, yet their controlled generation inside living cells remains challenging. Here, we develop an ultrasound-responsive potassium sodium niobate–gold (KNN@Au) piezoelectric nanoheterojunction functionalized with hyaluronic acid (KNN@Au-HA) to enable in situ terminal protein sulfonation. Under ultrasound excitation, the dynamic modulation of KNN polarization generates a piezo-potential that facilitates interfacial charge separation and electron transfer, promoting the single-electron reduction of O2 to •O2–. Meanwhile, Au–S coordination positions thiol substrates in close proximity to the catalytic surface, facilitating the subsequent multistep oxidation of cysteine thiols to the terminal −SO3H state. Using this platform, we identify ribosomal protein RPL32 as a functionally relevant sulfonation target and resolve sulfonation at Cys96 by mass spectrometry. This modification disrupts ribosomal proteostasis, induces NRF2 nuclear translocation and stress signaling, and converts colorectal cancer cells into a competitive “loser” state that undergoes neighbor-dependent apoptotic elimination. In HCT116 xenograft-bearing mice, ultrasound-activated KNN@Au-HA suppresses colorectal tumor growth; analysis of patient-derived single-cell transcriptomic data reveals RPL32 upregulation as a hallmark of the malignant “winner” state, establishing a functional match between this competition therapy and colorectal cancer. Together, these findings demonstrate that piezocatalytic protein modification can chemically reprogram cellular competitive fitness without genome editing, providing a proof of concept for nongenetic competition therapy against cancer.

Journal of the American Chemical Society
Tongji University (CN), Chinese Academy of Sciences (CN), Fudan University (CN), Shanghai Institute of Ceramics (CN), Zhejiang University (CN)
Nanoplatforms for cancer theranostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon